Skip to main content
Caplight Logo









neuraxpharm

neuraxpharm

Private
—N/Ahttps://neuraxpharm.com

Last Round

Debt

Jul 11, 2025

Last Round Size

$1.9B

Est. Valuation

$1.9B

Total Funding Raised

$1.9B

Company Overview

A specialty pharmaceutical company focused on the treatment of the central nervous system (CNS).

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

neuraxpharm Comparables

Compare neuraxpharm with similar companies based on industry and business-model similarity.

No public comparables are available for neuraxpharm. Request access to learn about comparables coverage.

Request access

neuraxpharm Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtJul 11, 2025
Buyout/LBOSep 22, 2020
Buyout/LBOJul 8, 2016
View all Funding Rounds

neuraxpharm Filings

Explore SEC and related filing metadata, where available.

neuraxpharm filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Firmographic Details

Headquarters—
Year Founded1985
Last FundingJul 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?